Evidence map›Paper›PMID 24581499›Full record

ArticleCell2014

Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor.

Veronica Rodriguez-Bravo, John Maciejowski, Jennifer Corona, Håkon Kirkeby Buch, Philippe Collin, Masato T Kanemaki, Jagesh V Shah, Prasad V Jallepalli

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 166 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Micronuclei: origins, assays, mechanisms, diseases and treatments.Signal transduction and targeted therapy · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Nuclear transport proteins: structure, function, and disease relevance.Signal transduction and targeted therapy · 2023
    Review
  14. Article
  15. Principles and dynamics of spindle assembly checkpoint signalling.Nature reviews. Molecular cell biology · 2023
    Review
  16. Mechanisms of chromosomal instability (CIN) tolerance in aggressive tumors: surviving the genomic chaos.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2023
    Review
  17. Article
  18. Article
  19. The large cytoplasmic volume of oocyte.The Journal of reproduction and development · 2023
    Review
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Veronica Rodriguez-BravoMolecular Biology Program and Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
John MaciejowskiMolecular Biology Program and Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jennifer CoronaMolecular Biology Program and Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Håkon Kirkeby BuchSwiss Federal Institute of Technology Zürich, CH-8093 Zürich, Switzerland; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Philippe CollinThe Gurdon Institute and Department of Zoology, University of Cambridge, Cambridge CB2 1QN, UK.
Masato T KanemakiCenter for Frontier Research, National Institute of Genetics, ROIS, and Department of Genetics, SOKENDAI, Yata 1111, Mishima, Shizuoka 411-8540, Japan.
Jagesh V ShahDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Prasad V JallepalliMolecular Biology Program and Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: jallepap@mskcc.org.
Memorial Sloan Kettering Cancer Center · USÉcole Polytechnique Fédérale de Lausanne · CHHarvard University · USNational Institute of Genetics · JPWellcome/Cancer Research UK Gurdon Institute · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Regulation of Chromosome Segregation in Human CellsR01GM094972 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI JALLEPALLI, PRASAD V · 2010 to 2021
$5.3M
Quantitative Measurements and Modeling of the Mitotic CheckpointR01GM077238 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHAH, JAGESH V · 2007 to 2011
$2.0M
Biotechnology and Biological Sciences Research CouncilNCI NIH HHS P30 CA008748NIGMS NIH HHS R01GM077238NIGMS NIH HHS R01 GM094972NIGMS NIH HHS R01GM094972Wellcome Trust 092096
6 · The paper itself

Abstract

The spindle assembly checkpoint (SAC) delays anaphase until all chromosomes are bioriented on the mitotic spindle. Under current models, unattached kinetochores transduce the SAC by catalyzing the intramitotic production of a diffusible inhibitor of APC/C(Cdc20) (the anaphase-promoting complex/cyclosome and its coactivator Cdc20, a large ubiquitin ligase). Here we show that nuclear pore complexes (NPCs) in interphase cells also function as scaffolds for anaphase-inhibitory signaling. This role is mediated by Mad1-Mad2 complexes tethered to the nuclear basket, which activate soluble Mad2 as a binding partner and inhibitor of Cdc20 in the cytoplasm. Displacing Mad1-Mad2 from nuclear pores accelerated anaphase onset, prevented effective correction of merotelic errors, and increased the threshold of kinetochore-dependent signaling needed to halt mitosis in response to spindle poisons. A heterologous Mad1-NPC tether restored Cdc20 inhibitor production and normal M phase control. We conclude that nuclear pores and kinetochores both emit "wait anaphase" signals that preserve genome integrity.

Indexed as

AnaphaseM Phase Cell Cycle CheckpointsActive Transport, Cell NucleusCell Cycle ProteinsDimerizationHCT116 CellsHeLa CellsHumansInterphaseKinetochoresMad2 ProteinsMitosisNuclear PoreNuclear ProteinsCell Cycle ProteinsMAD1L1 protein, humanMAD2L1 protein, humanMad2 ProteinsNuclear Proteins

Identifiers

PMID24581499
PMCPMC3947552
OpenAlexW2054722813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.